5G8-30510-26325
3 vaccinations
4 coded responses
32 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 180 / PA
- Registered
- 2021-11-26
- Relationship
- Child or adolescent in my care
- Guardian
- ZH2-16937-78630
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-06
Dose 1 — Pfizer-BioNTech
-
2021-11-26
Registered in v-safe
- 2021-11-26
- 2021-11-29
-
2021-12-01
Dose 2 — Pfizer-BioNTech
- 2021-12-01
-
2021-12-02
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2021-12-03
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-07
- 2021-12-08
-
2021-12-15
Survey response — day 14, dose 2, dependentMedDRA: Body temperature increased, Oropharyngeal pain — Feeling: PoorFree text: Fever 100 degrees F and sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-12-22
Survey response — day 21, dose 2, dependentMedDRA: Body temperature increased, Influenza virus test negative, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fever of 100 degrees, sore throat, covid/strep/flu negativeMedDRA releases: 2024-11 · check-in free text available
-
2021-12-22
Report sent to call center — day 21, dose 2, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-23
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-29
- 2022-01-05
- 2022-01-12
- 2022-03-02
- 2022-06-01
-
2022-06-24
Dose 3 — Pfizer-BioNTech
-
2022-06-25
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-01
-
2022-07-08
Survey response — day 14, dose 3, dependentMedDRA: Cough, Fatigue, Oropharyngeal pain, Pyrexia — Feeling: FairFree text: Cough, fever of up to 102, sore throat, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-07-15
- 2022-07-22
- 2022-07-29
- 2022-08-05
-
2022-09-23
Survey response — 3 months, dose 3, dependentMedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Covid infection august 14,2022MedDRA releases: 2024-11 · check-in free text available
- 2022-12-23
- 2023-06-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-06 | Pfizer-BioNTech | No |
| 2 | 2021-12-01 | Pfizer-BioNTech | No |
| 3 | 2022-06-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-22 | Successful 2021-12-23 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — day 14, dose 2, dependent
Symptoms: Fever 100 degrees F and sore throat
Release 10 — day 21, dose 2, dependent
Symptoms: Fever of 100 degrees, sore throat, covid/strep/flu negative
Release 12 — day 14, dose 3, dependent
Symptoms: Cough, fever of up to 102, sore throat, fatigue
Release 12 — 3 months, dose 3, dependent
Symptoms: Covid infection august 14,2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Influenza virus test negative | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release